Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 352 of the 356 references it cites were found in a registry or an index; none of the 390 sources its claims cite is checked for support yet.
Abstract
OBJECTIVE: The aim was to formulate practice guidelines for the diagnosis and treatment of polycystic ovary syndrome (PCOS). PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer developed the guideline. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Two systematic reviews were conducted to summarize supporting evidence. CONCLUSIONS: We suggest using the Rotterdam criteria for diagnosing PCOS (presence of two of the following criteria: androgen excess, ovulatory dysfunction, or polycystic ovaries). Establishing a diagnosis of PCOS is problematic in adolescents and menopausal women. Hyperandrogenism is central to the presentation in adolescents, whereas there is no consistent phenotype in postmenopausal women. Evaluation of women with PCOS should exclude alternate androgen-excess disorders and risk factors for endometrial cancer, mood disorders, obstructive sleep apnea, diabetes, and cardiovascular disease. Hormonal contraceptives are the first-line management for menstrual abnormalities and hirsutism/acne in PCOS. Clomiphene is currently the first-line therapy for infertility; metformin is beneficial for metabolic/glycemic abnormalities and for improving menstrual irregularities, but it has limited or no benefit in treating hirsutism, acne, or infertility. Hormonal contraceptives and metformin are the treatment options in adolescents with PCOS. The role of weight loss in improving PCOS status per se is uncertain, but lifestyle intervention is beneficial in overweight/obese patients for other health benefits. Thiazolidinediones have an unfavorable risk-benefit ratio overall, and statins require further study.
Overview
CoChat Summary
TL;DR
This Endocrine Society clinical practice guideline recommends using the Rotterdam criteria to diagnose PCOS in adults and emphasizes excluding mimics and assessing associated metabolic, cardiovascular, endometrial, mood, and sleep morbidity. It recommends hormonal contraceptives as first-line management for menstrual abnormalities and hirsutism/acne, clomiphene (or comparable estrogen modulators) as first-line therapy for anovulatory infertility, and metformin for T2DM/IGT or as second-line therapy for menstrual irregularity when hormonal contraceptives cannot be used.
Key findings
- PCOS diagnosis in adults should be made if two of three Rotterdam criteria are met—androgen excess, ovulatory dysfunction, or polycystic ovaries—after excluding thyroid disease, hyperprolactinemia, and nonclassic congenital adrenal hyperplasia; in adolescents, diagnosis should require clinical and/or biochemical hyperandrogenism plus persistent oligomenorrhea, because anovulatory symptoms and PCO morphology are not sufficient.
- Women with PCOS are at increased risk for impaired glucose tolerance and type 2 diabetes: the guideline states a 5- to 10-fold increased risk of developing T2DM, with overall glucose intolerance prevalence of 30–35% and T2DM in 3–10%; nonobese women with PCOS had 10–15% IGT and 1–2% T2DM.
- Hirsutism is present in approximately 65–75% of patients with PCOS, and PCOS represents the major cause of hirsutism; in a large study of patients with clinical hyperandrogenism, 72.1% of 950 patients were diagnosed with PCOS.
- Endometrial cancer risk is increased: a 31-year UK follow-up showed a 3.5 increased relative risk, and a meta-analysis reported RR = 2.7 (95% CI, 1.0–7.29), confirmed by a subsequent systematic review with a 3-fold increased risk.
- Depression and sleep-disordered breathing are also increased: one study reported major depression episode/recurrent depression OR 3.8 (95% CI, 1.5–8.7; P = .001) and suicide attempts seven times higher in PCOS cases vs controls; women with PCOS were 30 times more likely to have sleep-disordered breathing and nine times more likely to have daytime sleepiness after controlling for BMI.
Methods
- An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer developed the guideline using the GRADE system to describe recommendation strength and evidence quality.
- Consensus was reached through one group meeting, several conference calls, and e-mail communications; committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts.
- Two systematic reviews were conducted to summarize supporting evidence; recommendations use “we recommend” with number 1 for strong recommendations and “we suggest” with number 2 for weak recommendations, with cross-filled circles indicating evidence quality.
Limitations
- The guideline states that there are no adequately powered, randomized, double-blind, placebo-controlled trials in adolescents with PCOS; no large randomized trials of exercise in PCOS; and no long-term data assessing the effect of hormonal contraceptives on glucose tolerance in nondiabetic and diabetic women with PCOS.
- It states that there are currently no diagnostic criteria for PCOS in perimenopausal and menopausal women, no age-related testosterone cutoffs, and that testosterone assays used to diagnose hyperandrogenemia in women are imprecise.
- It notes that the Rotterdam ultrasound PCO criteria were not validated for adolescents, that there is a lack of well-defined cutoff points for androgen levels during normal pubertal maturation, and that many recommendations are weak because evidence is limited or inconclusive.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 201 Not checked · 50 Own results and interpretations
In the paper
“However, hirsutism was a major symptom in about 60% of adolescents in one study (27) and may be suggestive of PCOS in adolescents (28).”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 1.0 Diagnosis of PCOS
What the sources say
- Not checked yetcites [27] Pfeifer SM, Kives S Polycystic ovary syndrome in the adolescent. Obstet Gynecol Clin North Am. 2009; 36: 129– 152. 19344852
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“but our systematic review did not confirm this (211).”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
What the sources say
- Not checked yetcites [211] Domecq JP, Prutsky G, Mullan R, et al Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis [published online ahead of print October 3, 2013]. J Clin Endocrinol Metab. doi: 10.1210/jc.2013–2385. 24092832
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“although there were significant improvements in some metabolic parameters (mainly glycemic effects related to improvements in fasting blood glucose and insulin levels) (249, 250).”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
What the sources say
- Not checked yetcites [249] Tang T, Glanville J, Orsi N, Barth JH, Balen AH The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006; 21: 1416– 1425. 16501038
- Not checked yetcites [250] Domecq JP, Prutsky G, Mullan R, et al Adverse effects of common treatments for polycystic ovary syndrome: a systematic review and meta-analysis [published online ahead of print October 3, 2013]. J Clin Endocrinol Metab. doi: 10.1210/jc.2013-2374. PMC5399491 24092830
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found little evidence to support lifestyle change as an infertility treatment”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Our own meta-analysis showed that weight loss had minimal effects on hirsutism and fertility”
§ Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline > Method of Development of Evidence-Based Clinical Practice Guidelines > 3.0 Treatment
What the sources say
- Not checked yetcites [249] Tang T, Glanville J, Orsi N, Barth JH, Balen AH The use of metformin for women with PCOS undergoing IVF treatment. Hum Reprod. 2006; 21: 1416– 1425. 16501038
- Not checked yetcites [250] Domecq JP, Prutsky G, Mullan R, et al Adverse effects of common treatments for polycystic ovary syndrome: a systematic review and meta-analysis [published online ahead of print October 3, 2013]. J Clin Endocrinol Metab. doi: 10.1210/jc.2013-2374. PMC5399491 24092830
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
146 more claims
Create a free account to see all 252 claims and to verify the 390 references still open.
- It may state two separate claims as one. 78
- Probably not a substantial claim. 34
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Based on current guidelines, metformin is indicated in PCOS in some scenarios to improve fertility (Teede et al. , 2011; Legro et al. , 2013), for management of menstrual irregularity if women are unable to take OCPs, and in co-existent prediabetes or DM2, where lifestyle modification fails (Legro et al. , 2013).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Legro et al., 2013
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the interim there is inadequate evidence on the impact of metformin on glucose tolerance in prediabetes and DM2 specifically in PCOS, but based on data in general populations, current guidelines recommend using metformin in obese women with PCOS who have prediabetes or DM2 (Legro et al. , 2013).”
From Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis (2015) · cites this paper as Legro et al. , 2013
Experimental — accuracy not yet measuredIn the citing paper
“It is indicated in combination with COCs, especially for overweight or obese patients, or when COCs are contraindicated [46].”
From Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism (2022) · cites this paper as [46]
Citations
Cites
1 retracted
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedReduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477 · cited 1×
“implementation of evidence-based guidelines (4).”
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Self-citationThe diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 1×
“Cushing’s syndrome Many of the signs and symptoms of PCOS can overlap with Cushing’s (ie, striae, obesity, dorsocervical fat (ie, buffalo hump, glucose intolerance); however, Cushing’s is more likely to be present when a large number of signs and symptoms, especially those with high discriminatory index (eg, myopathy,…”
BackgroundThe Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712 · cited 1×
“Overall, hirsutism is present in approximately 65–75% of patients with PCOS (although lower in Asian populations) (15, 52).”
BackgroundPhysical Fitness and All-Cause Mortality: A Prospective Study of Healthy Men and Women
Blair, S. N. (1989) · JAMA · doi:10.1001/jama.1989.03430170057028 · Cited by 2,658 · cited 1×
“diovascular fitness, as measured by maximal oxygen consumption during exercise, is an independent predictor of cardiovascular mortality (229).”
BackgroundAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · cited 1×
“Similarly, androgen levels decline with age in women with and without PCOS (serum T declines 50% between the ages of 20 and 40 y) (43–45), with reports of improved menstrual frequency in PCOS (46, 47), although there is little evidence to support a decline in serum T associated with the menopause transition per se (43…”
BackgroundSelf-citation
Research works printed but not linked: 1
- [286]Tanner JM Growth and endocrinology of the adolescent. In: Gardner LI, ed. Endocrine and Genetic Diseases of Childhood and Adolescents. 2nd ed Philadelphia, PA: WB Saunders: 1975: 14.
Cited by
Items 801–900 of 1,004
Xu, A., Fan, Y., Liu, S., Sheng, L., Sun, Y., & Yang, H. (2022) · Journal of Ovarian Research · doi:10.1186/s13048-022-01092-z · Cited by 18
A prospective cohort study of infertility and cancer incidence
Wang, S., Gaskins, A. J., Farland, L. V., Zhang, D., Birmann, B. M., Rich-Edwards, J. W., Wang, Y., Tamimi, R. M., Missmer, S. A., & Chavarro, J. E. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.02.028 · Cited by 18
A Comprehensive Approach in Diagnosing the Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2015) · Women s Health · doi:10.2217/whe.15.13 · Cited by 18
Self-citationBoshku, A. A., Panova, D. I., & Ivanovska, B. Z. (2018) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2018.346 · Cited by 18
Ho, C.-W., Chen, H.-H., Hsieh, M., Chen, C., Hsu, S.-P., Yip, H., & Kao, C. (2020) · Annals of Translational Medicine · doi:10.21037/atm-19-4763 · Cited by 18
“To our knowledge, PCOS was associated with metabolic syndrome, insulin resistance, diabetes, obesity, dyslipidemia, HTN, and CVD (14,19,20), and the common mechanisms were higher insulin level or low grade chronic inflammation due to high estrogen secretion influenced by the hypothalamicpituitary-gonadal axis (21).”
BackgroundInfluentialŞahin, S. B., Durakoğlugil, T., Ayaz, T., Şahin, O. Z., Durakoğlugil, M. E., Sümer, F., Aktaş, E., & Alyildiz, N. (2015) · Endocrine Practice · doi:10.4158/ep14435.or · Cited by 18
Yasmin, A., Roychoudhury, S., Sengupta, P., Ahmed, A. B. F., Madhu, N. R., Choudhury, A. P., Kolesárová, A., Dutta, S., & Rosas, I. M. (2025) · Therapeutic Advances in Reproductive Health · doi:10.1177/26334941251384195 · Cited by 18
Resistance Training as Therapeutic Management in Women with PCOS: What is the Evidence?
Wright, P. J., Corbett, C. F., Pinto, B. M., Dawson, R. M., & Wirth, M. D. (2021) · International journal of exercise science · doi:10.70252/neex8658 · Cited by 18
“Accordingly, the Endocrine Society Clinical Practice Guidelines on the Diagnosis and Treatment of PCOS recommend exercise and physical activity as first-line treatment to combat chronic disease risk yet details about what type of exercise are not included (23).”
BackgroundMethodInfluentialCharacterizing skeletal muscle dysfunction in women with polycystic ovary syndrome
McDonnell, T., Cussen, L., McIlroy, M., & O’Reilly, M. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221113140 · Cited by 18
Bahreiny, S. S., Harooni, E., Dabbagh, M. R., & Ebrahimi, R. (2023) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v21i5.13470 · Cited by 17
“One criterion for PCOS is based on the Rotterdam criteria, which demands the presence of 3 features: hyperandrogenism, polycystic ovaries on ultrasound, and menstrual irregularities (10, 11).”
BackgroundOvarian Torsion in Polycystic Ovary Syndrome: A Potential Threat?
Psilopatis, I., Damaskos, C., Garmpis, N., Vrettou, K., Garmpi, A., Antoniou, E., Chionis, A., Nikolettos, K., Kontzoglou, K., & Dimitroulis, D. (2023) · Biomedicines · doi:10.3390/biomedicines11092503 · Cited by 17
“The evaluation of mental health and quality of life, as well as metabolic screening and monitoring, should occur both at the initial visit and at regular intervals because women with PCOS are at a high risk of developing serious comorbidities [5].”
BackgroundSchiffer, L., Oestlund, I., Snoep, J. L., Gilligan, L. C., TAYLOR, A. E. R., Sinclair, A. J., Singhal, R., Freeman, A., Ajjan, R., Tiganescu, A., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202302131r · Cited by 18
Najdgholami, Z., Sedgi, F. M., Ghalishourani, S. S., Feyzpour, M., & Rahimlou, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1531762 · Cited by 17
Akpang, N., Kwiatkowski, J., Zaborowska, Ł., & Ludwin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094121 · Cited by 17
“In order to diagnose PCOS, it is essential to exclude other potential causes of the observed clinical features, including thyroid dysfunction, hyperprolactinemia, non-classical congenital adrenal hyperplasia (NCAH), androgen-secreting tumor, Cushing’s syndrome, and acromegaly [6].”
Fields, E. L., & Trent, M. (2016) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2015.4866 · Cited by 17
Carron, R., Simon, N., Gilman-Kehrer, E., & Boyle, D. K. (2018) · The Journal of Continuing Education in Nursing · doi:10.3928/00220124-20180320-06 · Cited by 17
Varikasuvu, S. R., Panga, J. R., & Satyanarayana, M. V. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1536736 · Cited by 17
“The beta cell dysfunction has also been reported to occur in PCOS patients [2,3].”
BackgroundPCOS diagnosis in adolescents: the timeline of a controversy in a systematic review
Vassalou, H., Sotiraki, M., & Michala, L. (2019) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2019-0024 · Cited by 17
Jiang, B., Xue, M., Xu, D., Song, Y., & Zhu, S. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1724601 · Cited by 17
“Patients were included if they met the following criteria: patients tallied with the diagnostic criteria [20] of PCOS, in which HOMA-IR more than 2.”
MethodRetractedWen, L., Lin, W., Li, Q., Chen, G., & Wen, J. (2020) · Obesity · doi:10.1002/oby.22795 · Cited by 18
“Patients with PCOS can consume oral contraceptive pills to control symptoms of hyperandrogenism or take insulin-sensitizing drugs, such as metformin or pioglitazone, to alleviate insulin resistance; however, these drugs can effectively improve insulin sensitivity without significant weight loss or even with body weigh…”
BackgroundMeng, J., & Zhu, Y. (2020) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2020.11.070 · Cited by 17
Fu, C., Chen, M., Zhang, W., Yin, H., Chen, G., Huang, Q., Yang, X., Chen, L., Lin, C., & Yin, G. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00781-5 · Cited by 17
“TT was most commonly used for PCOS diagnosis according to the instructions of the PCOS guidelines [8].”
MethodPolycystic ovary syndrome in adolescents with obesity
Fu, L., Qu, F., Pan, J., Wang, T., & Wang, F. (2021) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20200890 · Cited by 17
Patel‐Sanchez, N., Perito, E. R., Tsai, P., Raymond‐Flesch, M., Lodish, M. B., & Sarkar, M. A. (2023) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2022-0527 · Cited by 17
Erdeve, Ş. S., Keskın, M., Sağsak, E., Çenesiz, F., Çetinkaya, S. Ç., & Aycan, Z. (2016) · Hormone Research in Paediatrics · doi:10.1159/000446111 · Cited by 17
Amasha, H. A., & Heeba, M. F. (2014) · IOSR Journal of Nursing and health Science · doi:10.9790/1959-03140108 · Cited by 17
“In October 2013, the Endocrine Society released practice guidelines for the diagnosis and treatment of PCOS (8) .”
MethodHyperandrogenism, Hirsutism, and Polycystic Ovary Syndrome
Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00133-5 · Cited by 17
Self-citationPolycystic ovary syndrome in obstructive sleep apnea-hypopnea syndrome: an updated meta-analysis
He, J., Ruan, X., & Li, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1418933 · Cited by 16
Coles, N., Bremer, K., Kives, S., Zhao, X., & Hamilton, J. (2016) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2015.06.004 · Cited by 16
Ramos, C. O., Canton, A. P. M., Seraphim, C. E., de Faria, A. G., Tinano, F. R., Mendonca, B. B., Latronico, A. C., & Brito, V. N. (2021) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2021-0142 · Cited by 16
Zhang, L., Wang, Z., Kong, L., Liu, H., Ma, Z., Xu, M., Yushanjiang, S., Yuan, D., & Yu, L. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01415-5 · Cited by 17
“…who had been diagnosed with PCOS according to the Rotterdam criteria set by the American Society for Reproductive Medicine (ASRM) [22], the PCOS criteria set by the National Institute of Child Health and Human Development (NICHD), or the PCOS criteria of the androgen excess and PCOS Society [23].”
Effect of pilates on regulating menstrual cycle in females with polycystic ovarian syndrome
Nazir, S., & Sadhu, S. (2023) · European Journal of Obstetrics & Gynecology and Reproductive Biology X · doi:10.1016/j.eurox.2023.100271 · Cited by 16
Food, nutrition, and fertility: from soil to fork
Maitin‐Shepard, M., Werner, E. F., Feig, L. A., Chavarro, J. E., Mumford, S. L., Wylie, B. J., Rando, O. J., Gaskins, A. J., Sakkas, D., Arora, M., et al. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.12.005 · Cited by 16
Mizgier, M., Więckowska, B., Formanowicz, D., Lombardi, G., Brożek, A., Nowicki, M., Durkalec‐Michalski, K., Kędzia, W., & Jarząbek‐Bielecka, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-54100-1 · Cited by 16
A Narrative Review: Repurposing Metformin as a Potential Therapeutic Agent for Oral Cancer
Li, J.-H., Hsin, P.-Y., Hsiao, Y.-C., Chen, B., Zhuang, Z.-Y., Lee, C., Lee, W., Vo, T. T. T., Tseng, C.-F., Tseng, S.-F., et al. (2024) · Cancers · doi:10.3390/cancers16173017 · Cited by 16
“PCOS is often characterized by a reduction in mature follicles and corpora lutea, leading to impaired reproductive function, and is frequently associated with metabolic disturbances such as dyslipidemia, which increase the risk of cardiovascular diseases [35,36].”
BackgroundRibeiro, M. P., Lemos, C., Leal, C., Barreiro, M., Tomé, A., & Vale-Fernandes, E. (2025) · JBRA · doi:10.5935/1518-0557.20250040 · Cited by 17
Polycystic ovary syndrome and metabolic syndrome: the worrisome twosome?
Shah, D., & Rasool, S. (2015) · Climacteric · doi:10.3109/13697137.2015.1116505 · Cited by 16
Coagulation parameters predictive of polycystic ovary syndrome
Sun, Q., Yang, Y., Peng, X., Zhang, Y., Gao, Y. J., Wang, F., Zhang, Y., Feng, W., Yang, W. S., & Kang, X. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2019.06.018 · Cited by 16
Butler, A. E., Abouseif, A., Dargham, S. R., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-75109-2 · Cited by 16
From adolescent PCOS to adult MAFLD: opposing effects of randomised interventions
de Zegher, F., Díaz, M., & Ibáñez, L. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2020-000574 · Cited by 16
Sun, Q., Gao, Y. J., Yang, J., Lu, J., Feng, W., & Wen, Y. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00776-z · Cited by 16
Ke, Y., Hu, J., Zhu, Y., Wang, Y., Chen, S., & Liu, S. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00841-1 · Cited by 16
“Polycystic ovary syndrome (PCOS), the most common endocrine disease in females during the reproductive period [20, 21], often presents with severe metabolic disorders [20] and is particularly linked to insulin resistance [22].”
BackgroundKarakaya, C., Çil, A. P., Bilgüvar, K., Çakır, T., Karalök, M. H., Karabacak, O., & Çağlayan, A. O. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15187 · Cited by 16
Long, T., Zhang, Y., Zeng, C., Zheng, S., Zhou, L., & Liu, H. (2022) · International Journal of Endocrinology · doi:10.1155/2022/9927240 · Cited by 17
Progress of oxidative stress in endometrium decidualization
Gao, W., Feng, F., Ma, X., Zhang, R., Li, L., Yue, F., Lv, M., & Liu, L. (2022) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2022.2144171 · Cited by 16
“It is a reproductive endocrine disorder characterised by hyperandrogenemia, persistent anovulation and polycystic changes of the ovary (Legro et al. 2013).”
BackgroundDiagnostic criteria for polycystic ovary syndrome
Kiran, Z. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87932-3.00018-9 · Cited by 16
Синдром полікістозних яєчників у щоденній практиці
Urbanovych, A. (2018) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.14.1.2018.127090 · Cited by 16
A Review on “Polycystic Overy Syndrom PCOS”
Morang, D., Chasta, P., & Chandrul, K. K. (2019) · International Journal of Trend in Scientific Research and Development · doi:10.31142/ijtsrd23542 · Cited by 16
Stefanaki, C., Bacopoulou, F., Kandaraki, E., Boschiero, D., & Diamanti‐Kandarakis, E. (2019) · Nutrients · doi:10.3390/nu11092055 · Cited by 16
“Body mass index (BMI) is an inadequate means of body composition assessment, as it measures the degree of excess body weight but not the lean and fat body masses, both of which influence morbidity and mortality [5].”
BackgroundNeuroendocrine Effects of Carnitines on Reproductive Impairments
Petrillo, T., Battipaglia, C., Virmani, A., Genazzani, A. R., & Genazzani, A. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910781 · Cited by 16
Sun, Q., Yuan, G., Yang, J., Lu, J., Feng, W., & Yang, W. (2021) · doi:10.1101/2021.06.29.21259512 · Cited by 15
Yoost, J., Ruley, M., Smith, K., Santanam, N., & Cyphert, H. A. (2022) · Women s Health Reports · doi:10.1089/whr.2022.0060 · Cited by 15
“Obese PCOS subjects also have increased androgens and fasting insulin levels compared with obese controls without PCOS.(1,6) Despite an increased prevalence of obesity among women with PCOS, it is also known that normal weight PCOS patients also have an increased risk for metabolic disturbance.”
BackgroundInfluentialAl-Mohaidly, M. T., Asmari, A. K. A., Khan, H. A., Alshngeetee, A., Khan, I., Al-Asmari, Y. A., Al-Hussain, G. O., Alsalem, S. S., Khan, A., Babtain, A. M., et al. (2023) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-023-02894-5 · Cited by 15
Myricetin ameliorates polycystic ovary syndrome in mice by brown adipose tissue activation
Zheng, N., Wang, C., Li, Y., Fu, H., & Hu, T. (2024) · Reproduction · doi:10.1530/rep-24-0034 · Cited by 15
Female-specific risk factors for cardiovascular disease: an update
Theodorou, A., Karagiannakis, D. S., Stefanaki, K., Kassi, E., Peppa, Μ., Vryonidou, A., & Paschou, S. Α. (2024) · HORMONES · doi:10.1007/s42000-024-00576-5 · Cited by 16
Polycystic Ovary Syndrome and Eating Disorders—A Literature Review
Góral, A., Żywot, K., Zalewski, W., Jagodziński, A., & Murawski, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm14010027 · Cited by 16
Kushawaha, B., Rem, T. T., & Pelosi, E. (2025) · Biomolecules · doi:10.3390/biom15060834 · Cited by 15
Mani, H., Potdar, N., & Gleeson, H. K. (2014) · Clinical Endocrinology · doi:10.1111/cen.12501 · Cited by 15
Nezi, M., CHRISTOPOULOS, P. F., Paltoglou, G., Gryparis, A., Bakoulas, V., Deligeoroglou, E., Creatsas, G. C., & Mastorakos, G. P. (2016) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0312 · Cited by 15
Goetsch, A. L., Kimelman, D., & Woodruff, T. K. (2017) · Springer eBooks · doi:10.1007/978-3-319-52316-3_14 · Cited by 15
Leon, G., de Klerk, E., Ho, J., Jackman, M., Reimer, R. A., Connors, K. E., & Luca, P. D. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0245 · Cited by 15
Anisya, V., Rodiani, R., & Graharti, R. (2019) · Medical Profession Journal of Lampung · Cited by 15
Pathophysiology of Polycystic Ovarian Syndrome
Manu, Soni, T., Victoria, V., & Prabhakar, P. K. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.101921 · Cited by 15
Han, Y., Lin, B., Lu, W., Wang, X., Tang, W., Tao, X., Cai, H., He, C., & Liu, C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1057376 · Cited by 11
Yadav, V., & Sharma, Y. (2023) · The Indian Journal of Pediatrics · doi:10.1007/s12098-023-04678-7 · Cited by 15
Mott, M. M., Kitos, N. R., & Coviello, A. D. (2014) · Endocrine Practice · doi:10.4158/ep13414.or · Cited by 15
“For example, obesity rates in our population were less than rates reported in the literature, 40 versus 70%, which could be attributed to the fact that less than half of patients had a recorded BMI (518/1,159, 45%) (7).”
BackgroundResultInfluentialKhalifah, R. A. A., Flórez, I. D., Dennis, B. B., Neupane, B., Thabane, L., & Bassilious, E. (2015) · Systematic Reviews · doi:10.1186/s13643-015-0105-4 · Cited by 15
“The diagnosis of PCOS will be based on the known PCOS diagnostic criteria: Endocrine Society Guidelines, NIH criteria, Rotterdam criteria, and the Androgen Excess Society criteria [6, 7, 10].”
BackgroundMethodClomiphene for anovulatory infertility.
Davidson, R., Motan, T., & Korownyk, C. S. (2016) · Europe PMC (PubMed Central) · Cited by 15
Should we individualize lipid profiling in women with polycystic ovary syndrome?
Poromaa, I. S., Mellembakken, J. R., Morin-Papunen, L. C., Piltonen, T., Puurunen, J., Tapanainen, J. S., Stener‐Victorin, E., Hirschberg, A. L., Vanky, E., Ravn, P., et al. (2016) · Human Reproduction · doi:10.1093/humrep/dew228 · Cited by 15
INSULIN RESISTANCE AND POLYCYSTIC OVARY SYNDROME IN A CHINESE POPULATION
Chen, C., Jing, G., Zhou, L., Juan, S., Bin, C., & Jie, H. (2017) · Endocrine Practice · doi:10.4158/ep171849.or · Cited by 16
Zhang, B., Qi, X., Zhao, Y., Li, R., Zhang, C., Chang, H., Pang, Y., & Qiao, J. (2018) · Reproductive Sciences · doi:10.1177/1933719118756772 · Cited by 15
Association between red blood cell distribution width and polycystic ovary syndrome
Yılmaz, Ö., Çalan, M., Kelekçi, S., & Temür, M. (2014) · Endocrine Research · doi:10.3109/07435800.2014.987398 · Cited by 15
“18 pg/mL) (20–22), (3) typical ultrasonographic finding of polycystic ovarian morphology (with one ovary being sufficient for diagnosis), defined as the presence of 12 or more follicles measuring 2–9 mm in diameter and/or ovarian volume of greater than 10 mL (without a cyst or dominant follicle) in either ovary (20).”
BackgroundPolycystic ovary syndrome is associated with increased osteopontin levels
Saklamaz, A., Çalan, M., Yilmaz, O., Küme, T., Temür, M., Yildiz, N., Kasap, E., Genç, M., Yürekli, B. Ş., & Kocabaş, G. Ü. (2016) · European Journal of Endocrinology · doi:10.1530/eje-15-1074 · Cited by 15
Liu, Z., Liu, C., Hao, C., Xue, Q., Huang, X. Y., Zhang, N., Bao, H., & Qu, Q. (2016) · Gynecological Endocrinology · doi:10.3109/09513590.2016.1138463 · Cited by 15
“and polycystic ovaries [1], accounting for 75% of anovulatory infertility worldwide [2].”
BackgroundPolycystic ovary syndrome in patients with hair thinning
Prasad, S., Souza, B. D., Burns, L. J., Lippincott, M. F., & Senna, M. M. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.01.075 · Cited by 14
“Identification of PCOS is critical given that these women have a higher risk for metabolic syndrome, some malignancies and infertility [2].”
The Role of T Cells in Ovarian Physiology and Infertility
Knapik, L. O., Paresh, S., Nabi, D., & Brayboy, L. M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.713650 · Cited by 14
Ge, J., Yang, N., Zhang, X., Li, M., Zhang, W., He, J. B., Zhu, H., Cheng, X., Shen, S., & Ge, W. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-00985-0 · Cited by 14
“Elevated androgen levels are observed in nearly 80% of American PCOS women and 50% of European PCOS women [20, 21].”
BackgroundMetformin Improves the Hepatic Steatosis Index in Non-Obese Patients with Polycystic Ovary Syndrome
Riemann, A., Blaschke, M., Jauho-Ghadimi, A., Siggelkow, H., & Gollisch, K. S. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154294 · Cited by 14
“Polycystic ovary syndrome (PCOS), also known as Stein–Leventhal syndrome, is the most common metabolic disorder and a frequent cause of anovulatory infertility in young women [6].”
BackgroundVasudevan, S., Gautam, R., Maan, P., Arora, A., Ganie, M. A., Jabbar, P. K., & Arora, T. K. (2025) · Frontiers in Reproductive Health · doi:10.3389/frph.2025.1627670 · Cited by 14
Moin, A. S. M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100079 · Cited by 14
“Using an immunometric assay with fluorescence detection on the DPC Immulite 2000 analyzer (Euro/DPC, Llanberis, UK) and following the manufacturer’s recommended protocol, TSH, prolactin, insulin, C reactive protein (CRP), DHEAS, and sex hormone binding globulin (SHBG) levels were determined [13].”
Revisión de los criterios diagnósticos para el síndrome de ovario poliquístico
Lara, P. D. R., Contreras, O., Ramirez‐Velandia, F., Sanguino, A. J. S., & Agudelo, J. S. (2020) · Revista Médicas UIS · doi:10.18273/revmed.v33n3-2020002 · Cited by 15
Białka, A., Orszulak, D., Gawlik, A., & Drosdzol-Cop, A. B. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1000261 · Cited by 14
Kalhor, M., Mohammadi, E., Shahali, S., Amini, L., & Moghaddam-Banaem, L. (2022) · International Journal of Reproductive BioMedicine (IJRM) · doi:10.18502/ijrm.v20i9.12062 · Cited by 14
“Therefore, after PCOS diagnosis, it is essential to screen for psychological disorders and refer to appropriate counseling centers, if needed (52).”
BackgroundBonab, S. B., & Parvaneh, M. (2023) · Science & Sports · doi:10.1016/j.scispo.2022.11.001 · Cited by 15
“higher prevalence of hyperprolactinemia has been reported in patients with PCOS [11, 12].”
Gourgari, E., Spanakis, E. K., & Dobs, A. S. (2016) · International Journal of Women s Health · doi:10.2147/ijwh.s104825 · Cited by 14
“the Androgen Excess Society 2006 criteria require the presence of hyperandrogenism (biochemical or clinical) with either oligoanovulation or polycystic ovaries.(1) The”
BackgroundMethodInfluentialShould metformin be included in fertility treatment of PCOS patients?
Haas, J., & Bentov, Y. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.01.012 · Cited by 14
Genotype based Risk Predictors for Polycystic Ovary Syndrome in Western Saudi Arabia
Bakhashab, S., & Ahmed, N. (2019) · Bioinformation · doi:10.6026/97320630015812 · Cited by 14
Dreyer, A. F., Jensen, R. C., Glintborg, D., Schmedes, A., Brandslund, I., Nielsen, F., Kyhl, H. B., Jensen, T. K., & Andersen, M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa292 · Cited by 14
Alizadeh, F., Ramezani, M., & Piravar, Z. (2020) · Middle East Fertility Society Journal · doi:10.1186/s43043-020-0015-9 · Cited by 14
Bağır, G. Ş., Bakıner, O., Bozkırlı, E., Cavlak, G., Serinsöz, H., & Ertörer, M. E. (2015) · Medical Principles and Practice · doi:10.1159/000440810 · Cited by 14
Marakaki, C., Pervanidou, P., Papassotiriou, I., Mastorakos, G. P., Hochberg, Z., Chrousos, G. P., & Papadimitriou, A. (2018) · Stress · doi:10.1080/10253890.2018.1484446 · Cited by 14
“Recent guidelines suggest that women and adolescents with PCOS be screened for anxiety and depression (Legro et al., 2013).”
BackgroundResistência insulínica na Síndrome dos Ovários Policísticos deve ser sempre tratada?
Soares, J. M., de Sá, M. F. S., & Baracat, E. C. (2014) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032014000200001 · Cited by 14
Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome
Kamrul-Hasan, A. B. M., Aalpona, F. T. Z., & Selim, S. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.1.1.54 · Cited by 13
Polycystic Ovary Syndrome: pathogenesis, management, and treatment with metals and organic compounds
Al-Kareem, T. A. A., Hassan, S., & Abdalhadi, S. M. (2024) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2023.406103.1160 · Cited by 14
Lee, H., Song, D., Kwon, J., Han, E., Chang, M.-J., & Kang, H.-Y. (2018) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-018-1123-2 · Cited by 13
“Patients with a diagnosis history of polycystic ovarian syndrome (PCOS) during the study period were also excluded from the study cohort as they take metformin [23], which is a first-line glucose lowering drugs prescribed [27].”
Carreau, A., Jin, E. S., Garcia‐Reyes, Y., Rahat, H., Nadeau, K. J., Malloy, C. R., & Cree‐Green, M. (2019) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00047.2019 · Cited by 13
Update on polycystic ovary syndrome
Kim, J. (2021) · Daehan saengsik uihak hoeji/Clinical and experimental reproductive medicine · doi:10.5653/cerm.2020.04329 · Cited by 13
“The 2013 Endocrine Society guideline recommends metformin for PCOS patients who have type 2 diabetes or impaired glucose tolerance in whom lifestyle modification fails [11].”
BackgroundMethodShetty, S. S., Kumari, S., Hegde, P., Roopashree, P. G., & Suhasini, P. C. (2022) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2022.102222 · Cited by 13
Joshi, B. N., Patil, A. D., Kokate, P., Akula, A., Shaikh, S. A., Tandon, D., & Nayak, A. (2022) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-022-01723-x · Cited by 13
“Hence, guidelines [13, 14] recommend screening for psychological well-being in all women with PCOS.”
BackgroundMetformin therapy in pediatric type 2 diabetes mellitus and its comorbidities: A review
Alfaraidi, H., & Samaan, M. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1072879 · Cited by 13
Metadata
- Authors
- Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K.
- Affiliations
- Pennsylvania State University (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2013-12
- Volume
- 98
- Issue
- 12
- Pages
- 4565-4592
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC5399492
- OpenAlex
- W2120973019
- Cited by
- 1,919
- References
- 356
- Citations by year
- 2026: 104 · 2025: 135 · 2024: 149 · 2023: 181 · 2022: 207 · 2021: 197 · 2020: 149 · 2019: 160 · 2018: 145 · 2017: 129 · 2016: 131 · 2015: 124 · 2014: 95 · 2013: 6
- FWCI
- 143.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- European Society of Endocrinology
- National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020595, P30DK020595)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD065029)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, PCOS diagnosis, Rotterdam criteria, hyperandrogenism, ovulatory dysfunction, PCOS treatment, hormonal contraception, clomiphene citrate, metformin, insulin resistance, menstrual irregularity, hirsutism, acne, infertility, adolescents, menopausal women, weight loss, lifestyle intervention, thiazolidinediones, statins, cardiovascular risk
- MeSH terms
- Adolescent, Adult, Age Factors, Female, Humans, Middle Aged, Polycystic Ovary Syndrome, Societies, Scientific, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.